arrow
J

Jun Kawashima

yokohama city university school of medicine
H指数:17
被引数:1,438

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of severe postoperative complications after curative-intent resection for perihilar cholangiocarcinoma: an international multi-institutional analysis

根治性切除术后严重并发症对肝门部胆管癌预后的影响:一项国际多中心分析

HPB
IF2.4
2026-08-220
OAAI
Genotype-Phenotype Associations Underlying Very Early Recurrence After Intrahepatic Cholangiocarcinoma Resection

肝内胆管癌切除术后极早期复发的基因型-表型关联

2026-05-010
PRE
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy

Akabane, M.; Imaoka, Y.; Kawashima, J.; Pawlik, T.M. 推进肝细胞癌的精准医学:液体活检、免疫微环境、单核苷酸多态性和转化治疗领域的当前挑战与未来方向。Hepatic Oncol. 2025, 12, 2493457. [Google Scholar] [CrossRef] [PubMed]

2025-12-318
PRE
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count

辅助化疗对肝门部胆管癌的生存获益:转移淋巴结计数对数优势比的影响

Surgery
IF2.7
2025-12-010
PRE
Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasis

早期与晚期结直肠癌肝转移行切除术患者的临床病理特征、基因组特征及预后

Surgery
IF2.7
2025-11-280
PRE
Beyond the Composite: Differential Impact of Albumin and Bilirubin Relative to Tumor Burden in HCC

超越综合指标:白蛋白和胆红素相对于肝癌肿瘤负荷的差异化影响

2025-11-260
PRE
Minimally invasive surgery for hepatocellular carcinoma: evolving trade-offs of patient selection and recurrence risk

微创手术治疗肝细胞癌:患者选择与复发风险权衡的演变

2025-11-011
PRE
Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified Tumor Burden Score

结直肠癌肝转移患者行肝切除术后复发模式的时间变化风险及改良肿瘤负荷评分的作用

2025-10-200
PRE
ASO Visual Abstract: Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma

ASO视觉摘要:术前系统性免疫炎症指数预测临床淋巴结阴性的肝内胆管癌的隐匿性淋巴结疾病

2025-08-230
PRE
The Surgical Burden Score: A Novel Continuous Metric for Predicting Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma

手术负担评分:一种预测肝细胞癌肝切除术后并发症的新型连续指标

HPB
IF2.4
2025-08-210
PRE
An easy-to-use online calculator to identify patients least likely to benefit from surgical resection of intrahepatic cholangiocarcinoma

一个易于使用的在线计算器,用于识别从肝内胆管癌手术切除中获益可能性最小的患者

Surgery
IF2.7
2025-07-140
PRE
Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma

术前系统性免疫炎症指数可预测临床淋巴结阴性肝内胆管癌的隐匿性淋巴结转移

2025-07-090
OAAI
International validation of a natural-killer-cell–based model to predict recurrence-free survival in hepatocellular carcinoma

基于自然杀伤细胞模型的肝癌无复发生存预测模型的国际验证

HPB
IF2.4
2025-07-030
PRE